The Procter & Gamble Company (NYSE:PG) Shares Bought by Unigestion Holding SA

Unigestion Holding SA grew its position in shares of The Procter & Gamble Company (NYSE:PG) by 22.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 272,441 shares of the company’s stock after purchasing an additional 49,947 shares during the quarter. Procter & Gamble makes up about 2.3% of Unigestion Holding SA’s portfolio, making the stock its 7th biggest holding. Unigestion Holding SA’s holdings in Procter & Gamble were worth $47,179,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in PG. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble during the third quarter valued at $33,000. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter worth about $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PG. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research report on Thursday, August 29th. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $180.45.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 52.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 83,080 shares of company stock valued at $14,629,038. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $172.38 on Wednesday. The company’s 50 day simple moving average is $170.71 and its 200-day simple moving average is $169.44. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $180.43. The company has a market capitalization of $405.96 billion, a price-to-earnings ratio of 29.72, a price-to-earnings-growth ratio of 3.68 and a beta of 0.44.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the prior year, the firm earned $1.83 earnings per share. The firm’s revenue was down .6% compared to the same quarter last year. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.34%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.